InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Rabinowitz Michael. Director active across 1 company, notably Oramed Pharmaceuticals INC.. Cumulatively, 2 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €17k. History available since 3 January 2023. The latest transaction was disclosed on 3 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations